Skip to main content

The role of reactive oxygen species in myocardial redox signaling and regulation.

Publication ,  Journal Article
Moris, D; Spartalis, M; Tzatzaki, E; Spartalis, E; Karachaliou, G-S; Triantafyllis, AS; Karaolanis, GI; Tsilimigras, DI; Theocharis, S
Published in: Annals of translational medicine
August 2017

Reactive oxygen species (ROS) are subcellular messengers in gene regulatory and signal transduction pathways. In pathological situations, ROS accumulate due to excessive production or insufficient degradation, leading to oxidative stress (OS). OS causes oxidation of DNA, membranes, cellular lipids, and proteins, impairing their normal function and leading ultimately to cell death. OS in the heart is increased in response to ischemia/reperfusion, hypertrophy, and heart failure. The concentration of ROS is determined by their rates of production and clearance by antioxidants. Increases in OS in heart failure are primarily a result of the functional uncoupling of the respiratory chain due to inactivation of complex I. However, increased ROS in the failing myocardium may also be caused by impaired antioxidant capacity, such as decreased activity of Cu/Zn superoxide dismutase (SOD) and catalase (CAT) or stimulation of enzymatic sources, including, cyclooxygenase, xanthine oxidase (XO), nitric oxide synthase, and nonphagocytic NAD(P)H oxidases (Noxs). Mitochondria are the main source of ROS during heart failure and aging. Increased production of ROS in the failing heart leads to mitochondrial permeability transition, which results in matrix swelling, outer membrane rupture, a release of apoptotic signaling molecules, and irreversible injury to the mitochondria. Alterations of "redox homeostasis" leads to major cellular consequences, and cellular survival requires an optimal regulation of the redox balance.

Duke Scholars

Published In

Annals of translational medicine

DOI

EISSN

2305-5847

ISSN

2305-5839

Publication Date

August 2017

Volume

5

Issue

16

Start / End Page

324

Related Subject Headings

  • 42 Health sciences
  • 32 Biomedical and clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Moris, D., Spartalis, M., Tzatzaki, E., Spartalis, E., Karachaliou, G.-S., Triantafyllis, A. S., … Theocharis, S. (2017). The role of reactive oxygen species in myocardial redox signaling and regulation. Annals of Translational Medicine, 5(16), 324. https://doi.org/10.21037/atm.2017.06.17
Moris, Demetrios, Michael Spartalis, Eleni Tzatzaki, Eleftherios Spartalis, Georgia-Sofia Karachaliou, Andreas S. Triantafyllis, Georgios I. Karaolanis, Diamantis I. Tsilimigras, and Stamatios Theocharis. “The role of reactive oxygen species in myocardial redox signaling and regulation.Annals of Translational Medicine 5, no. 16 (August 2017): 324. https://doi.org/10.21037/atm.2017.06.17.
Moris D, Spartalis M, Tzatzaki E, Spartalis E, Karachaliou G-S, Triantafyllis AS, et al. The role of reactive oxygen species in myocardial redox signaling and regulation. Annals of translational medicine. 2017 Aug;5(16):324.
Moris, Demetrios, et al. “The role of reactive oxygen species in myocardial redox signaling and regulation.Annals of Translational Medicine, vol. 5, no. 16, Aug. 2017, p. 324. Epmc, doi:10.21037/atm.2017.06.17.
Moris D, Spartalis M, Tzatzaki E, Spartalis E, Karachaliou G-S, Triantafyllis AS, Karaolanis GI, Tsilimigras DI, Theocharis S. The role of reactive oxygen species in myocardial redox signaling and regulation. Annals of translational medicine. 2017 Aug;5(16):324.

Published In

Annals of translational medicine

DOI

EISSN

2305-5847

ISSN

2305-5839

Publication Date

August 2017

Volume

5

Issue

16

Start / End Page

324

Related Subject Headings

  • 42 Health sciences
  • 32 Biomedical and clinical sciences